TR200101722T2 - Serivastatin ve fibratların birleşimi. - Google Patents

Serivastatin ve fibratların birleşimi.

Info

Publication number
TR200101722T2
TR200101722T2 TR2001/01722T TR200101722T TR200101722T2 TR 200101722 T2 TR200101722 T2 TR 200101722T2 TR 2001/01722 T TR2001/01722 T TR 2001/01722T TR 200101722 T TR200101722 T TR 200101722T TR 200101722 T2 TR200101722 T2 TR 200101722T2
Authority
TR
Turkey
Prior art keywords
serivastatin
fibrates
combination
disorders
methylglutalyl
Prior art date
Application number
TR2001/01722T
Other languages
English (en)
Inventor
Ippen Joachim
Schopen Ulrike
Ziegler Reiner
Schckler Fritz
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of TR200101722T2 publication Critical patent/TR200101722T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

Bu bulus, 3-hidroksi-3- metilglutaril-konzim A yavaslatici serivastatin ile fibratlarin birlesimi ve bunun propilaside ve lipid metabolizma rahatsizliklarinin ve hastaliklarinin ve bunlardan kaynaklanan bozukluklarin tedavisinde kullanilmasi ile alakalidir.
TR2001/01722T 1998-12-18 1999-12-06 Serivastatin ve fibratların birleşimi. TR200101722T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19858789A DE19858789A1 (de) 1998-12-18 1998-12-18 Kombination von Cerivastatin und Fibraten

Publications (1)

Publication Number Publication Date
TR200101722T2 true TR200101722T2 (tr) 2001-11-21

Family

ID=7891784

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01722T TR200101722T2 (tr) 1998-12-18 1999-12-06 Serivastatin ve fibratların birleşimi.

Country Status (19)

Country Link
US (1) US6511985B1 (tr)
EP (1) EP1140082A1 (tr)
KR (1) KR20010093845A (tr)
CN (1) CN1330544A (tr)
AR (1) AR021643A1 (tr)
AU (1) AU3035600A (tr)
BR (1) BR9916270A (tr)
CA (1) CA2355295A1 (tr)
CO (1) CO5160272A1 (tr)
DE (1) DE19858789A1 (tr)
GT (1) GT199900214A (tr)
HN (1) HN1999000208A (tr)
IL (1) IL143221A0 (tr)
PE (1) PE20001325A1 (tr)
PL (1) PL349389A1 (tr)
SV (1) SV1999000250A (tr)
TR (1) TR200101722T2 (tr)
WO (1) WO2000037078A1 (tr)
ZA (1) ZA200103918B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024169A1 (en) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
EP1414496B1 (en) 2001-08-07 2010-10-20 Galephar M/F Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
WO2003013607A1 (en) * 2001-08-07 2003-02-20 Galephar M/F ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR
DE10200138A1 (de) * 2002-01-04 2003-07-17 Karl Winkler Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
CA2526730A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
ATE428411T1 (de) * 2003-11-07 2009-05-15 Jj Pharma Inc Hdl-verstärkende kombinationstherapie-komplexe
MX2007009281A (es) * 2005-02-10 2007-09-25 Lufecycle Pharma As Composicion farmaceutica estable que comprende una combinacion de dosis fija de fenofibrato y un inhibidor de 3-hidroxi 3-metilglutaril-coenzima a reductasa.
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
US20070269503A1 (en) * 2006-05-16 2007-11-22 James Walter Burgess Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
BRPI0714361A2 (pt) * 2006-07-14 2013-03-26 Ranbaxy Lab Ltd polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
CN101534825A (zh) * 2006-08-04 2009-09-16 Aska制药株式会社 含有贝特类药物的制剂及其制备方法
TWI407955B (zh) 2007-03-29 2013-09-11 Kowa Co 高脂血症之預防及／或治療劑
WO2023146320A1 (ko) * 2022-01-28 2023-08-03 동광제약 주식회사 로수바스타틴 또는 이의 약학적으로 허용되는 염 및 페노피브레이트를 함유하는 캡슐 제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (tr) 1980-11-19 1986-01-10 Laruelle Claude
AU1422388A (en) 1987-01-27 1988-08-10 Warner-Lambert Company Lipid regulating compositions
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2039763A1 (en) * 1990-04-30 1991-10-31 Henry Y. Pan Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
FR2737121B1 (fr) 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
NZ520176A (en) * 1997-07-31 2005-02-25 Kos Life Sciences Inc Combinations of HMG-CoA reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night

Also Published As

Publication number Publication date
DE19858789A1 (de) 2000-06-21
AU3035600A (en) 2000-07-12
GT199900214A (es) 2001-06-08
BR9916270A (pt) 2001-09-04
WO2000037078A1 (de) 2000-06-29
CA2355295A1 (en) 2000-06-29
PE20001325A1 (es) 2000-12-30
PL349389A1 (en) 2002-07-15
CN1330544A (zh) 2002-01-09
KR20010093845A (ko) 2001-10-29
US6511985B1 (en) 2003-01-28
IL143221A0 (en) 2002-04-21
HN1999000208A (es) 2000-11-22
EP1140082A1 (de) 2001-10-10
SV1999000250A (es) 2000-10-16
CO5160272A1 (es) 2002-05-30
ZA200103918B (en) 2002-05-15
AR021643A1 (es) 2002-07-31

Similar Documents

Publication Publication Date Title
TR200101722T2 (tr) Serivastatin ve fibratların birleşimi.
MXPA02007915A (es) Mediador de lipido activado por aspirina.
BR0007556A (pt) Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos
FI963070A0 (fi) Klooripyrimidiinivälituotteita
TR199701074T1 (tr) Sinerjistik bilesimler.
ES2135062T3 (es) Pirazolo y pirrolopiridinas.
BR9508245A (pt) Método para inhibir metástase de cáncer por administração oral de pectina citrica modificada solúvel
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
HUP9904368A2 (hu) Colostrinin és alkalmazása
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
ATE203519T1 (de) Chinolinderivate als antimalariamittel
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
BR0009211A (pt) Derivados de resorcinol
PT1143917E (pt) Derivados anticonvulsionantes uteis no tratamento da perturbacao de stress pos-traumatico
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
DK0977871T3 (da) Neurotrypsin
TR200002939T2 (tr) Paroksetin maleat
NO20005548L (no) Mykobakterieinhibitorer
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
DE69838686D1 (de) Tripeptidylpeptidaseinhibitoren
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
MD1473F2 (en) Antiherpetic remedy
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
TR199800705T2 (tr)